QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
OTCMKTS:EPGNY

Epigenomics - EPGNY News Today

$2.39
0.00 (0.00%)
(As of 03/23/2023 12:00 AM ET)
Add
Compare
Today's Range
$2.39
▼
$2.39
50-Day Range
$2.39
▼
$9.56
52-Week Range
$2.01
▼
$2.39
Volume
62 shs
Average Volume
100 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Get Epigenomics News Delivered to You Automatically

Sign up to receive the latest news and ratings for EPGNY and its competitors with MarketBeat's FREE daily newsletter.


EPGNY Media Mentions By Week

EPGNY Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

EPGNY
News Sentiment
▼
-0.64

0.35
▲
Average
Medical
News Sentiment

EPGNY News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

EPGNY Articles
This Week
▼
1

0
▲
EPGNY Articles
Average Week

SourceHeadline
uk.finance.yahoo.com logoEpigenomics AG: Adjustment of guidance and notice of loss pursuant to sec. 92 para. 1 of the German Stock Corporation Act
uk.finance.yahoo.com - March 20 at 5:51 PM
benzinga.com logoSample Preparation in Genomics, Proteomics, and Epigenomics Global Market Report 2023: Increased R&D Spending in Developing Economies Boosts Sector
benzinga.com - March 14 at 11:50 PM
uk.finance.yahoo.com logoEpigenomics AG: Revocation of admission to the Prime Standard (sub-segment of the regulated market with additional post-admission obligations)
uk.finance.yahoo.com - March 10 at 8:11 AM
marketwatch.com logoPersonalized Medicine and Epigenomics Market Capitalizing on Market Growth: Essential Insights from Our Latest Research Report
marketwatch.com - February 21 at 9:27 AM
uk.finance.yahoo.com logoEpigenomics AG: Resignation of Supervisory Board Chairman Heino von Prondzynski
uk.finance.yahoo.com - January 27 at 2:57 PM
markets.businessinsider.com logoEQS-News: Epigenomics AG: Resignation of Supervisory Board Chairman Heino von Prondzynski
markets.businessinsider.com - January 27 at 2:57 PM
markets.businessinsider.com logoEQS-News: Pareto Securities AS publishes buy recommendation for Epigenomics AG share
markets.businessinsider.com - December 23 at 7:49 AM
markets.businessinsider.com logoEQS-Adhoc: Epigenomics AG: Further raise of earnings guidance for the current fiscal year 2022
markets.businessinsider.com - December 21 at 9:05 AM
markets.businessinsider.com logoEQS-Adhoc: Epigenomics Releases Performance Data on Next Generation Test
markets.businessinsider.com - December 14 at 10:03 AM
uk.finance.yahoo.com logoEpigenomics Releases Performance Data on Next Generation Test
uk.finance.yahoo.com - December 14 at 1:27 AM
markets.businessinsider.com logoEQS-News: Epigenomics Releases Performance Data on Next Generation Test
markets.businessinsider.com - December 14 at 1:27 AM
markets.businessinsider.com logoEQS-News: Epigenomics Licenses Protein Biomarker Technology for Blood-based Colorectal Cancer Test
markets.businessinsider.com - December 14 at 1:27 AM
markets.businessinsider.com logoEQS-Adhoc: Epigenomics AG: Raise of earnings guidance for the current fiscal year 2022 due to currency gains and lower study costs
markets.businessinsider.com - September 19 at 8:20 AM
uk.finance.yahoo.com logoEpigenomics Initiates prospective multi-center clinical trial for “Next-Generation” blood-based colorectal cancer test
uk.finance.yahoo.com - September 19 at 3:20 AM
markets.businessinsider.com logoEQS-News: Epigenomics Initiates prospective multi-center clinical trial for Next-Generation blood-based colorectal cancer test
markets.businessinsider.com - September 19 at 3:20 AM
markets.businessinsider.com logoDGAP-Adhoc: Epigenomics AG: Capital reduction planned at a ratio of 4 : 1
markets.businessinsider.com - September 9 at 4:12 PM
uk.finance.yahoo.com logoEpigenomics AG: Notice of Loss pursuant to Sec. 92 par. 1 AktG
uk.finance.yahoo.com - August 15 at 4:10 AM
markets.businessinsider.com logoDGAP-News: Epigenomics AG: Notice of Loss pursuant to Sec. 92 par. 1 AktG
markets.businessinsider.com - August 15 at 4:10 AM
markets.businessinsider.com logoDGAP-News: Epigenomics AG Reports Financial Results for the First Six Months of 2022
markets.businessinsider.com - August 10 at 2:38 PM
uk.finance.yahoo.com logoEpigenomics AG Reports Financial Results for the First Quarter of 2022
uk.finance.yahoo.com - May 11 at 5:38 AM
markets.businessinsider.com logoDGAP-News: Epigenomics AG Reports Financial Results for the First Quarter of 2022
markets.businessinsider.com - May 11 at 5:38 AM
marketwatch.com logoGlobal Personalized Medicine and Epigenomics Market 2022 Opportunity Assessment, Key Drivers and Challenges, Growth Rate and Forecast to 2028
marketwatch.com - March 30 at 12:29 PM
markets.businessinsider.com logoDGAP-News: Epigenomics AG Reports Financial Results for Fiscal Year 2021
markets.businessinsider.com - March 24 at 4:21 AM
nasdaq.com logoEPGNY After-Hours Quotes
nasdaq.com - January 14 at 8:43 PM
nasdaq.com logoEPGNY Real-Time Quotes
nasdaq.com - January 6 at 7:25 AM
markets.businessinsider.com logoDGAP-News: Epigenomics AG publishes financial results for the first nine months 2021
markets.businessinsider.com - November 10 at 8:55 AM
uk.finance.yahoo.com logoEpigenomics AG places maximum number of mandatory convertible bonds with a total volume of EUR 16.5 million
uk.finance.yahoo.com - September 13 at 8:24 AM
uk.finance.yahoo.com logoEpigenomics AG: Execution of a Biobank Sale Agreement and Update of Guidance
uk.finance.yahoo.com - August 17 at 5:34 PM
finance.yahoo.com logoSonim Announces Software Development Relationship with Coforge
finance.yahoo.com - December 22 at 9:06 AM
finance.yahoo.com logoSonim to Transfer Shenzhen Manufacturing Responsibilities to Unicair
finance.yahoo.com - December 18 at 8:18 AM
finance.yahoo.com logoSonim XP5s Ultra-rugged Feature Phone Now Supported by Mission-Critical Standards Based FirstNet® PTT Solution from AT&T
finance.yahoo.com - December 8 at 1:15 PM
marketwatch.com logoEpigenomics Market 2020 Global Share, Size, Future Demand, Global Research, Top Leading Players, Emerging Trends, Region by Forecast to 2026
marketwatch.com - December 3 at 2:37 AM
finance.yahoo.com logoDo Hedge Funds Love Sonim Technologies, Inc. (SONM)?
finance.yahoo.com - December 3 at 2:37 AM
finance.yahoo.com logoSonim Technologies to Present at the virtual Fall Investor Summit on November 16th-18th
finance.yahoo.com - November 12 at 9:03 AM
finance.yahoo.com logoSonim Announces Rugged Handheld and Tablet with Integrated Barcode Scanners
finance.yahoo.com - November 11 at 9:11 AM
uk.finance.yahoo.com logoEpigenomics AG hosts conference call on preliminary CMS reimbursement decision
uk.finance.yahoo.com - October 21 at 12:02 AM
uk.finance.yahoo.com logoEpigenomics AG: U.S. Centers for Medicare & Medicaid Services publish negative proposed NCD for Epi proColon
uk.finance.yahoo.com - October 16 at 11:43 PM
in.finance.yahoo.com logoEPIGENOMICS AG NA O.N. (ECX.DU)
in.finance.yahoo.com - October 14 at 6:41 PM
marketwatch.com logoHealthcare Biomarkers Market Report Reviews Drivers, Analysis, Share, Growth, Trends & Forecast to 2026
marketwatch.com - September 14 at 12:29 PM
marketwatch.com logoQuotient Ltd.
marketwatch.com - September 10 at 5:01 PM
uk.finance.yahoo.com logoEpigenomics AG: CMS Still Actively Working on Proposed Decision Memo with Goal to Publish As Soon As Possible
uk.finance.yahoo.com - August 31 at 11:21 PM
marketwatch.com logoPrecision Cancer Diagnostic Tests Market : Facts, Figures and Analytical Insights 2020-2026
marketwatch.com - August 26 at 12:29 PM
marketwatch.com logoHealthcare Biomarkers Market Research By Growth, Competitive Methods And Forecast To 2026
marketwatch.com - August 20 at 1:26 PM
businesswire.com logoInsights on the Global Fecal Occult Testing Market 2020-2024 |COVID-19 Analysis, Drivers, Restraints, Opportunities and Threats | Technavio
businesswire.com - August 14 at 5:12 PM
barrons.com logoEpigenomics AG
barrons.com - August 14 at 12:12 PM
finance.yahoo.com logoNew study published in the Journal of the National Cancer Institute concludes that Epi proColon® is the test of choice for the millions of individuals not willing to participate in FIT or colonoscopy screening
finance.yahoo.com - August 10 at 8:19 AM
www.marketwatch.com logoHealthcare Biomarkers Market Study Report (2020-2027), Competitive Analysis, Proposal Strategy, Potential Targets, Assessment And Recommendations
www.marketwatch.com - August 3 at 9:55 AM
finance.yahoo.com logoEncode Ideas, L.P. to host Virtual 1x1 Webinar with Epigenomics AG (ECX.DE, EPGNF) on Tuesday, July 28th at 10:30 AM ET
finance.yahoo.com - July 23 at 8:59 AM
finance.yahoo.com logoIs Sonim Technologies, Inc. (NASDAQ:SONM) Trading At A 48% Discount?
finance.yahoo.com - July 2 at 2:50 PM
finance.yahoo.com logoNextNav partners with Sonim Technologies to deliver innovative z-axis capabilities for public safety and E911
finance.yahoo.com - July 1 at 8:21 AM
Get Epigenomics News Delivered to You Automatically

Sign up to receive the latest news and ratings for EPGNY and its competitors with MarketBeat's FREE daily newsletter.

This page (OTCMKTS:EPGNY) was last updated on 3/23/2023 by MarketBeat.com Staff